WebNews

Please enter a web search for web results.

NewsWeb

ECIKS. org
eciks. org > 6202-22383-nyse-listings-expand-with-tarsier-pharma-ipo-eyes-8-to-10-share-price

NYSE listings expand with Tarsier Pharma IPO, eyes $8 to $10 share price

3+ hour, 54+ min ago  (426+ words) The biotech IPO market sat dormant for much of 2024 and 2025, with only 11 drugmakers pricing public offerings during that stretch. But 2026 marks a distinct inflection point. According to equity research analysts, the sector could see 30 to 35 biotech IPOs throughout the year…...

Symbols: nyse:gmrs,nyse:rol,nyse:mane,nasdaq:akts,btc-usd,nasdaq:btai
News Powered by Cision
news. cision. com > metsa-group > r > metsa-group-inaugurates-the-world-s-most-modern-tissue-mill-in-mariestad--sweden, c4354052

Mets" Group inaugurates the world's most modern tissue mill in Mariestad, Sweden

9+ hour, 31+ min ago  (376+ words) Mets" Group marked the inauguration of its expanded and modernised tissue paper mill in Mariestad, Sweden, on 26 May. The opening ceremony was conducted by external representatives together with Mets" Group and Mets" Tissue leadership. Mets" Group has made significant investments…...

Symbols: nasdaq:cnxu,btc-usd
WKZO
wkzo. com > 05/28/2026 > small-biotech-firms-quicker-to-latch-onto-ai-than-big-ones-says-tencent-healthcare-president

Small biotech firms quicker to "latch onto" AI than big ones, says Tencent Healthcare President

3+ hour, 51+ min ago  (236+ words) HONG KONG, May 28 (Reuters) " Small biotech firms "latch onto" AI more quickly than bigger firms, the head of Chinese tech giant Tencent's "healthcare division said on Thursday, as more "businesses embrace AI to improve efficiency. Pharmaceutical companies are also increasingly…...

Symbols: nyse:lly
Pulse 2. 0
pulse2. com > cero-therapeutics-profile-chris-ehrlich-interview

CERo Therapeutics: Interview With CEO Chris Ehrlich About The Immunotherapy Company

2+ hour, 19+ min ago  (511+ words) CERo Therapeutics is a clinical-stage immunotherapy company developing next-generation engineered T cell therapies (CER-T) that combine innate and adaptive immunity to enhance the body's ability to eliminate solid and hematological tumors. Pulse 2. 0 interviewed CERo Therapeutics CEO Chris Ehrlich to learn…...

Symbols: nasdaq:anix,btc-usd
Google News
pulse2. com > perceptic-12-million-raised-for-ai-operating-system-for-drug-development

Perceptic: $12 Million Raised For AI Operating System For Drug Development

2+ hour, 2+ min ago  (394+ words) Perceptic, an AI-first operating system for biopharma, officially emerged from stealth and announced $12 million in funding backed by investors including Accel, Air Street Capital, and Elder Gull, as reported by Fortune. The company said it has worked directly with global…...

Symbols: btc-usd
mida. gov. my
mida. gov. my > precision-medicine-malaysias-next-medical-frontier

Precision Medicine " Malaysia's Next Medical Frontier

12+ hour, 26+ min ago  (230+ words) This site is mobile responsive CGTPs represent one of the most important applications of precision medicine and represent a major advancement in medical science, particularly for diseases once considered difficult or even impossible to treat." Recognising the level of sophistication,…...

Symbols: btc-usd
Moneycontrol
moneycontrol. com > news > business > krivium-systems-unveils-proprietary-ip-portfolio-spanning-ai-clean-energy-oncology-13934787. html

Krivium Systems unveils proprietary IP portfolio spanning AI, clean energy, oncology

2+ hour, 5+ min ago  (279+ words) Moneycontrol. com Krivium Systems unveils proprietary IP portfolio spanning AI, clean energy, oncology Krivium Systems, a Jaipur-based technology firm has announced that its portfolio of proprietary technologies spanning artificial intelligence, clean energy infrastructure, consumer intelligence, and oncology research has achieved…...

Symbols: btc-usd
open PR. com
openpr. com > news > 4530219 > biosimilar-market-to-grow-at-18-7-cagr-driven-by-patent

Biosimilar Market to Grow at 18. 7% CAGR Driven by Patent Expirations and Rising Demand for Affordable Biologics

4+ hour, 47+ min ago  (73+ words) open PR. com Biosimilar Market to Grow at 18. 7% CAGR Driven by Patent Expirations and Rising Demand for Affordable Biologics Press release from: Fact. MR Permanent link to this press release: You can edit or delete your press release Biosimilar Market…...

Symbols: btc-usd
@PRNewswire
prnewswire. com > news-releases > reduce-supply-chain-delays-in-life-sciences-manufacturing-upcoming-webinar-hosted-by-xtalks-302783982. html

Reduce Supply Chain Delays in Life Sciences Manufacturing, Upcoming Webinar Hosted by Xtalks

3+ hour ago  (154+ words) May 28, 2026, 08: 30 ET Attendees will learn how to optimize key metrics like cost-to-service, inventory costs and patient outcomes while navigating the unique challenges of life sciences manufacturing. The featured speaker will also explore real-world insights and actionable strategies to future-proof supply…...

Symbols: btc-usd
Inkorr
inkorr. com > en > amp > cukerberg-vidkriv-bezkostovnij-si-dla-analizu-68-mlrd-bilkiv-327519

Zuckerberg Launches Free AI to Analyze 6. 8 Billion Proteins

4+ hour, 46+ min ago  (190+ words) inkorr. com Zuckerberg Launches Free AI to Analyze 6. 8 Billion Proteins Introducing Biohub: A New AI Model for Protein Research How This Model Could Transform Research Late last year, Biohub consolidated its various divisions under a single umbrella and also absorbed…...

Symbols: btc-usd,nasdaq:nvda,nyse:lly